Industry News
Glaukos at ESCRS 2025
The 2026 ESCRS meeting in Copenhagen was a highly successful and busy event for Glaukos, highlighted by the launch of iStent infinite®. The new device was prominently featured across podium presentations, booth speaker sessions, and hands-on dry labs, following its...
Raphaél Ervinckx joins Glaukos
Glaukos Corporation has appointed Raphaél Ervinckx as Vice President and General Manager for the EMEAI region, marking a strategic move to support the company’s continued international growth. Raphaël Ervinckx brings extensive experience in the ophthalmology sector, most recently serving as...
Andrew Geddes Becomes Vice President and Head of European Operations at Glaukos
Glaukos announces that Andrew Geddes is to become Vice President and Head of European Operations, recognising his eight years of leadership and contributions to the company’s growth. In this role, Geddes will lead Glaukos’ strategic expansion in Europe, Middle East...
Graham Popham joins Glaukos as Senior Director, Market Access EMEAI
Glaukos are delighted to announce the appointment of Graham Popham as Senior Director, Market Access EMEAI. Graham comments: "’I'm excited to join Glaukos at such a pivotal time in the evolution of ophthalmic care and growth of the organisation. Throughout...
Eye Juniors Introduction to the ST1 Application 2025-26
Join Eye Juniors for their Introduction to ST1 Ophthalmology Application 2025-2026. In this free talk high scoring trainees will talk you through the entire ST1 application process – from the MSRA and portfolio to the interview. They’ve been running the...
Sight Sciences at ESCRS
The Sight Sciences team recently returned from an incredibly busy and successful ESCRS congress in Copenhagen. The team were in town to support the MIGS masterclass programme and were pleased to spend time with customers, colleagues and contacts from across...
Biotech Healthcare unveils Optiflex XTENSE Comfort Plus at ESCRS 2025 (Copenhagen), marking a new era in Full Visual Range EDOF IOLs
Biotech Healthcare proudly introduced its newest advancement in intraocular lens technology — Optiflex XTENSE Comfort Plus, a Full Visual Range EDOF IOL, during the ESCRS 2025 meeting in Copenhagen. The product launch at Biotech’s booth drew widespread attention and appreciation...
Haag-Streit announces global launch of Elara 900 and Refractor 900 at ESCRS 2025
Bishop’s Stortford, UK – 12th September 2025 – Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is proud to announce the global launch of two new innovations:...
Heidelberg Engineering Celebrates Eye2Gene™ AI Breakthrough in Precision Ophthalmology
Heidelberg Engineering proudly announces a significant advance in the use of artificial intelligence for ophthalmic diagnostics, with the publication of the Eye2Gene™ study in Nature Machine Intelligence. Titled “Next-generation phenotyping of inherited retinal diseases from multimodal imaging with Eye2Gene”, the...
Heidelberg Engineering Welcomes Nick Capewell to the Clinical Sales Team
We’re delighted to welcome Nick Capewell to the clinical sales team at Heidelberg Engineering. Nick Capewell. Nick joins us after more than 10 years at University Hospitals Birmingham, where he trained and worked as an Ophthalmic Science Practitioner. Most recently,...
Glaukos Launches iStent infinite® in the UK Following MDR Approval
Glaukos has announced the launch of its latest glaucoma treatment, iStent infinite®, in the UK market after securing approval under the European Medical Device Regulation (MDR). This new approval process is rigorous and provides ophthalmologists with reassurance regarding the efficacy...
Haag-Streit UK announces appointment of Thomas Lenzen as new CEO
Haag-Streit UK is pleased to announce the appointment of Thomas Lenzen as the new Chief Executive Officer (CEO) of the Haag-Streit Group. Thomas Lenzen. With more than two decades of international leadership experience in the med tech industry, Thomas Lenzen...
